Insider · SEC Form 4 filer

David Pacitti

Companies

Where they file as an insider

Orchestra BioMed (OBIO) Director Latest filing Nov 9, 2026
Avanos Medical (AVNS) CEO Latest filing Jul 27, 2026

Track record

Did their buys beat the typical stock?

Open-market buys1
Quarters checked 6 months later0
Beat the typical stock —
Quarters too new to check1

Too soon to tell. None of their buys has a finished 6-month check yet.

Orchestra BioMed (OBIO) Bought Nov 9, 2026 · $100K · 20,000 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist